Table 2. Surgical management and debulking status of patients.
| Surgical procedures performed | No. (%) (n = 61) |
| TAH/BSO/Omentectomy/PLND& | 11(18) |
| TAH/BSO/PLND/evaluation of omentum | 4 (6.6) |
| TAH/BSO/Omentectomy$ | 8 (13.1) |
| TAH/BSO* | 18 (29.5) |
| TAH | 2 (3.3) |
| Subtotal hysterectomy/BSO/Omentectomy | 1 (1.6) |
| Subtotal hysterectomy/Omental biopsy | 1 (1.6) |
| Surgery aborted (open/close due to unresectable advanced disease) | 5 (8.2) |
| No surgery | 11 (18) |
| Debulking status | (n = 50) |
| Complete debulking | 28 (56) |
| Incomplete debulking | 14 (28) |
| Unknown | 8 (16) |
| Lymph nodes | (n = 15) |
| Total amount of lymph nodes removed | 284 |
| Mean (range) | 19 (1–43) |
| Number of node-positive patients | 4 (26.7) |
| Number of positive nodes | 7 (2.5) |
&Includes one patient that had additional sigmoidectomy with a Hartmann’s pouch and colostomy as part of debulking.
$Includes one patient that had a rectosigmoidectomy with a Hartmann’s pouch and colostomy.
*Includes one patient that had a vaginal hysterectomy and BSO.